In response to the systemic growth of COVID-19, HealthVerity has developed near-real-time reports and data packages to track the progress of the disease and monitor general healthcare utilization trends. Discover deeper insights into the wave of patients infected with COVID-19 and understand the serious impacts on non-infected patients whose habits have shifted as a result.
“The more detail we can obtain around how COVID-19 affects different patient populations, the faster a potential treatment for coronavirus can become a reality. Developing the expertise needed to apply diverse, real-world datasets to these issues is an essential step in this direction.”
M.D., Ph.D., FDA Principal Deputy Commissioner
For the second time since the inception of the index and onset of COVID-19 in March 2020, the index remains at a “Stable” level, reflecting consistent patient engagement across the US healthcare system. Infectious disease, an outlier versus other specialties, exceeded 100 and generated the highest score reported for any specialty since the inception of the HVPCI at 112.
HealthVerity and Aetion have launched the first and only real-time insights and evidence system.
Understand the general trends in healthcare utilization trends such as the number of well visits, sick visits and telehealth, both for COVID-19-related and unrelated visits by geography and specialty.
Upgrade options include daily delivery and/or automatic renewal for additional quarters.
Understand retrospective and prospective NPI-level insights into customer-selected disease or drug codes, well visits, hospital visits, and telehealth. Available at both the specialty and NPI level.
If the Physician profiling report is purchased, customer-specific codes can be added to either surveillance monitor above.
Understand the geographic spread of COVID-19 as well as the percentage of patients testing positive. Explore near-real-time results of COVID-19 lab tests from Quest Diagnostics and Private Source 74, two of the largest diagnostic lab companies in the US.
HealthVerity has developed a data package in response to the systemic growth of COVID-19 cases in early 2020. The key features of the package not only track the progress of the disease and related symptoms, but also offer general healthcare utilization trends. We can provide deeper insights around (1) physicians administering in-office treatments whose patients could be transitioned to a self-administered option and (2) lab testing for COVID-19 including results and ordering physician.
HealthVerity will utilize the raw medical claims data to calculate the unique number of patients across all combinations of patient zip, patient age, specialty, group and code. We calculate aggregate totals because patients can exist across multiple levels. For example, a patient may have a diagnosis for COVID-19 and also a diagnosis for cough, so we create an extra row of data where the group field is ’0Total’ and the patient is counted only once. Customers should not sum the patient column in the deliverable.
Yes. There is a place of service code as well as procedure codes which indicate when care was provided to the patient over the phone or online.
Our surveillance report includes medical claims data submitted by physicians to payers through the prior day. The actual date of service, the day the visit took place, will be on or prior to that time.
Across all lab providers, HealthVerity believes that it is seeing roughly 50% of all COVID-19 tests in the US.
Coronavirus has existed as a billable ICD-10 code since 2016; specifically diagnosis codes B97.29 and B34.2. The WHO released a new ICD-10 code specific to COVID-19 and the code is being adopted by the CDC as of April 1, 2020 (CDC Coding). Prior to April 1, 2020, all COVID-19 related billing reported one of the B-codes noted above (CDC Interim Coding).
“The traditional model for planning out research has been upended. COVID-19 has led to new real-world evidence research that focuses on the impact on non-infected patients who stay home because of the virus. We are now seeing a reshaping of research priorities to account for those rapid changes in patient behavior.”
CEO and Co-founder, HealthVerity